- AU$1.22bn
- AU$1.07bn
- AU$198.63m
- 99
- 23
- 64
- 69
Annual balance sheet for Nanosonics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 96 | 94.5 | 112 | 130 | 162 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 28.5 | 28.2 | 39.1 | 41.3 | 38.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 142 | 151 | 182 | 198 | 225 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.33 | 22.6 | 22.5 | 20.7 | 24.4 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 162 | 187 | 220 | 237 | 272 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19.5 | 28.6 | 33 | 32.2 | 39.8 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.7 | 48.5 | 56.1 | 55.1 | 62.6 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 136 | 139 | 164 | 182 | 210 |
| Total Liabilities & Shareholders' Equity | 162 | 187 | 220 | 237 | 272 |
| Total Common Shares Outstanding |